Blood Pressure

PEDIATRICS ◽  
1987 ◽  
Vol 80 (3) ◽  
pp. 459-460
Author(s):  
MYUNG K. PARK

To the Editor.— Recently the National Heart, Lung, and Blood Institute Task Force on Blood Pressure Control in Children published revised normal BP standards and guidelines for children.1 I welcome this effort, as reliable normative data have been unavailable but are prerequisite for the early detection of hypertension and its proper treatment. The guidelines published by the Task Force for the detection of hypertension, the diagnostic evaluation, follow-up laboratory testing, and treatment are, in my opinion, excellent.

PEDIATRICS ◽  
1978 ◽  
Vol 61 (6) ◽  
pp. 931-932
Author(s):  
Forrest H. Adams

Recently a Task Force of the National Heart, Lung and Blood Institute published a report in Pediatrics on blood pressure control in children.1 The report was good in many respects in that it presented in summary form a critique of what we currently know and do not know about blood pressure in children. Particularly good for pediatricians were the sections on methodology for measurement of blood pressure; mechanisms and causes of hypertension; evaluation of the hypertensive patient; and treatment of the hypertensive patient. The Task Force stressed the importance of further research in the field of blood pressure control in children and specifically recommended that physicians incorporate the measurement of blood pressure in the annual physical examination after 3 years of age.


PEDIATRICS ◽  
1982 ◽  
Vol 70 (1) ◽  
pp. 143-145
Author(s):  
Wallace W. McCrory

In a recent commentary,1 Adams and Landaw propose the novel concept that normally growing children need not have an associated progressive increase in blood pressure (BP). Noting that the National Heart, Lung and Blood Institute Task Force graphs to be used for plotting of pressure during growth and maturation show a continual increase of BP levels with age, they state that "Any implication that this is a healthy phenomenon associated with the aging process . . . is unjustified."2 To support this concept they cite data from studies in unacculturated tribes (ie, the Yanomamo Indians) showing that mean BP levels of these indians aged 0 to 50+, except for a slight increase from ages 0 to 9 years to 10 to 19 years, show no increase with age; this pattern is unlike that found in the United States and other Western cultures.


1981 ◽  
Vol 29 (11) ◽  
pp. 22-50 ◽  
Author(s):  
Helen O. Coburn

Under a contract with the National Heart, Lung, and Blood Institute, the Blue Cross and Blue Shield Associations carried out a demonstration project to determine how health insurers could utilize in-place systems and personnel to make worksite high blood pressure control programs more available to employee groups. When this project was initiated two and a half years ago, effective worksite-based programs had been developed in academic settings and tested in industry. Blue Cross and Blue Shield of Connecticut was selected by the national Blue Cross and Blue Shield Associations to serve as one of two demonstration test sites. The program is expanding to involve five additional Blue Cross and Blue Shield plans.


1981 ◽  
Vol 29 (11) ◽  
pp. 46-48

The National High Blood Pressure Education Program Coordinating Committee is a policymaking body whose purpose is to improve coordination and collaboration among national organizations involved in high blood pressure control. The Committee is composed of representatives of a number of professional and voluntary medical and health organizations. It is chaired and sponsored by the National Heart, Lung, and Blood Institute, National Institutes of Health. Among the activities of the Committee are defining priorities, exchanging views, promoting new initiatives in high blood pressure control, sponsoring a national conference, and coordinating High Blood Pressure Month in May of each year.


PEDIATRICS ◽  
1978 ◽  
Vol 61 (2) ◽  
pp. 333-336
Author(s):  
G. S. Berenson ◽  
A. W. Voors ◽  
L. S. Webber ◽  
R. R. Frerichs

The "Report of the National Heart, Lung, and Blood Institute's Task Force on Blood Pressure Control in Children" (Pediatrics suppl, May 1977) is a serious and long-needed attempt at establishing guidelines for practitioners in monitoring blood pressure levels in children and diagnosing early primary hypertension. Further, and importantly, it includes a consideration of prevention of future hypertensive disease, encouraging greater research and clinical interest in blood pressure in the pediatric age group. Specifically it encourages the physician examining children to include observations of blood pressure as a routine part of a physical examination.


2021 ◽  
Vol 80 (Suppl 1) ◽  
pp. 661.1-661
Author(s):  
Y. Sun ◽  
L. Ma ◽  
H. Chen ◽  
C. Rongyi ◽  
L. Jiang

Background:Hypertension occurred in 30-80% of TAK patients around the world. The occurrence of hypertension might severely worsen TAK prognosis. Nevertheless, data describing the specific imaging features in hypertensive TAK patients and the associations between hypertensive severity, blood pressure control status and long-term outcome were still lacking.Objectives:To investigate the characteristics and associations of hypertensive characteristics with adverse events-free survival in Takayasu arteritis (TAK) patients with hypertension.Methods:This research was based on a prospectively on-going observational cohort-East China Takayasu Arteritis (ECTA) cohort. In all, 618 TAK patients, who registered in the ECTA cohort up to December 2019, were enrolled. The main outcome was the adverse-events-free survival among hypertensive TAK patients during the follow-up ended on August 2020.Results:Totally, 204 (33.0%) patients suffered from hypertension, with 48 (23.5%), 62 (30.4%), and 94 (46.1%) mild, moderate, and severe hypertension, respectively. Cluster analysis indicated three imaging phenotypes for hypertensive TAK patients: Cluster 1: involvement of the abdominal aorta and/or renal artery (n=56, 27.5%); Cluster 2: involvement of the ascending aorta, thoracic aorta, and the aortic arch and its branches (n=38, 18.6%); Cluster 3: combined involvement of Cluster 1 and Cluster 2 (n=111, 54.4%). By the end of the follow-up, the blood pressure control rate was 50.8%, while the adverse-events-free survival was 67.9% in the entire hypertensive population. Multivariate Cox regression analysis indicated that well-controlled blood pressure (HR=2.13, 95%CI 1.32–3.78, p=0.047), co-existence of severe aortic valve regurgitation (HR=0.87, 95%CI 0.64–0.95, p=0.043), Cluster 1 (HR=0.69, 95%CI 0.48–0.92, p=0.017) and Cluster 3 (HR=0.72, 95%CI 0.43–0.94, p=0.048) imaging phenotype was associated with the adverse-events-free survival.Conclusion:Patients with controlled hypertension showed better adverse-events-free survival, while those with the Cluster 1 imaging phenotype were more likely to suffer from worse adverse-events-free survival. Hypertension occurred in 30-80% of TAK patients around the world. The occurrence of hypertension might severely worsen TAK prognosis.References:[1]Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol 2002; 55:481–6.[2]Watanabe Y, Miyata T, Tanemoto K. Current clinical features of new patients with Takayasu arteritis observed from a cross-country research in Japan: age and sex specificity. Circulation 2015; 132:1701–9.[3]Yilmaz N, Can M, Oner FA, et al. Impaired quality of life, disability and mental health in Takayasu’s arteritis. Rheumatol. (Oxford) 2013; 52:1898–904.[4]Laurent A, Julien H, Nicolas L, et al. Takayasu arteritis in France: a single-center retrospective study of 82 cases comparing white, North African, and black patients. Medicine 2010; 89:1–17.[5]Mwipatayi BP, Jeffery PC, Beningfield SJ, et al. Takayasu arteritis: clinical features and management: report of 272 cases. ANZ J Surg 2005; 75:110–7.Disclosure of Interests:None declared


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
C Delgado ◽  
M Delgado-Lelievre ◽  
D Lelievre ◽  
A Delgado-Almeida

Abstract Introduction The sodium voltage-gated channel alpha subunit 7 (SCN7A) has been associated to renal Na regulation and hypertension. This study explores the relationship between blood pressure (BP) and urinary overnight Na/K ratio (UONaK) in hypertensives (HT) and normotensive (NT) subjects from from National Heart, Lung and Blood Institute funded, Family Blood Pressure Program (FBPP) that were genotyped for 3 SNPs for SCN7A: CV2161217, CV 356958 and CV433036. Hypothesis Genetic variations in the SCNA7 are differently associated to BP and UONaK in HT and NT. Methods 1,749 subjects genotyped for SCN7A SNPs CV2161217, CV 356958 and CV433036 were analyzed from FBPP. Subjects with diastolic BP (DBP) ≥80 or systolic BP (SBP) ≥130 mmHg were classified HTN; subjects with SBP <130 and DBP <80 mmHg were classified as NT. UONAK was calculated by dividing overnight Na by K concentration. Correlation analysis done with partial variables (use of antihypertensive drug, use of diuretics, overnight urine creatinine). Results For the CV2161217, HTN group (n=1,030), 52% had C/C, 39% C/T and 9% T/T. In NT group (n=719), 52% had C/C, 38% C/T and 10% T/T. In the HT group, subjects with CC genotype showed strong correlation between DBP and UONaK (Fig 1a) while no significant correlation with SBP. Those with CT genotype maintained the correlation between SBP and UONaK (r=0.10, p=0.03) with no correlation with SBP. The TT showed no correlation between UONaK and SBP or DBP. In the NT, subjects with TT genotype showed strong correlation between DBP and UONaK (Fig 1b) and with SB (r=0.256, p=0.03). Those with CT or TT genotypes showed no correlation between UONaK and SBP or DBP. Similar finding were obtained for CV356958 SNP; no similar association was observed in the CV433036 SNP. Conclusions Subjects with the genetic variations in the SCNA7, such as CV2161217 and CV 356958 SNPs, showed significant correlation between blood pressure and overnight urinary sodium potassium. This finding could have important implications in non dipping status observed in some hypertensive patients. Funding Acknowledgement Type of funding source: None


Medicine ◽  
2016 ◽  
Vol 95 (14) ◽  
pp. e3233 ◽  
Author(s):  
Shangfeng Tang ◽  
Ghose Bishwajit ◽  
Lu Ji ◽  
Da Feng ◽  
Haiqing Fang ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document